- Added to Email Alerts
Hodgkin Lymphoma
Latest News View All
-
Risk of Dying From New Cancer Higher in Young Cancer Survivors -
AlertFDA OKs Trastuzumab Deruxtecan for Earlier Use in Breast Cancer
-
ESMO BCC 2022'No Discernible Benefit' Adding Nivolumab to ADC in Breast Cancer
-
'Unprecedented Crisis': Hodgkin Drug Shortage Persists
-
High Suicide, Depression Risks for Patients With Cancer
-
Mother and Baby Fine After First Reported Use of Immune-checkpoint Inhibitor During Pregnancy
-
When ImmunoTx Fails, HL Patients Should Get Timely Allo-HCT
-
Survivor's Story Foreshadows One of Oncology's Greatest Successes
Perspective View All
Journal Articles View All
-
Factors for Thyroid Complications After Radiation Therapy
-
Molecular Alterations and Immune Checkpoint Blockade
-
Immune Checkpoint Inhibitor Treatment Toxicity Risk in RA
-
Benefit of 5ASA Use After Anti-TNF or Immunomodulator in IBD
-
Cardiotoxicity of Immune Checkpoint Inhibitors
-
Erythema Nodosum: A Practical Approach and Diagnostic Algorithm
Additional Resources
Medscape Drugs & Diseases
- Hodgkin Lymphoma
- Lymphomas, Endocrine, Mesenchymal, and Other Rare Tumors of the Mediastinum
- Pediatric Hodgkin Lymphoma
- Thoracic Hodgkin Disease Imaging
Medscape Education